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The PLAT domain: a





kidney disease (ADPKD) has a
prevalence of 1 in 800 of the world’s
population and accounts for 10% of
individuals who require renal
replacement therapy, either dialysis
or transplantation. Renal cyst
formation occurs as part of a ‘two-
hit’ process in which inactivation of
both alleles of ADPKD genes leads
to abnormalities of cell proliferation,
apoptosis and differentiation [1]. Of
ADPKD cases, 85% are due to
mutations in the PKD1 gene, which
encodes a 4,302 amino acid protein,
polycystin-1 (PKD1), of unknown
function. Comparison of the PKD1
sequence with homologous
sequences from mouse and Fugu
predicts polycystin-1 to have a large
extracellular region of 3,000 amino
acid residues, a region containing
11 putative transmembrane
segments and a short intracellular
tail [2]. A well-defined extracellular
domain structure is apparent; the
presence of amino-terminal leucine-
rich repeats, a C-type-lectin domain
and multiple PKD repeats suggests a
role in cell–cell or cell–matrix
interactions (Figure 1) [3]. So far, no
extracellular ligands of polycystin-1
have been identified. Of the
intracellular regions of PKD1,
functional properties have been
defined only for the short 198 amino
acid carboxy-terminal region, which
contains a predicted coiled-coil
domain. These include a direct
interaction with the carboxyl
terminus of the protein encoded by
PKD2, polycystin-2 [4], activation of
R588 Current Biology, Vol 9 No 16
Figure 1
Schematic diagram of the domain
organisation of PLAT domain proteins.
Information and alignments for each of the
domains can be found in the Pfam database
[14,15] using the following identifiers or
accession numbers: leucine-rich repeats,
PF00560; C-type lectin, PF00059; LDL-A,
PF00057; PKD domains, PF00801; PLAT
domain, PF01477; lipoxygenase, PF00305;
Zn2+-dependent phospholipase C,
PF00882; lipase, PF00151. Abbreviation:
aa, amino acids.
PKD1_HUMAN (P98161)
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transcription factor AP-1 [5] and
activation of heterotrimeric
G proteins [6]. The last of these
occurs via a motif present in one of
polycystin-1’s most highly conserved
regions. Polycystin-1 may therefore
act as a cell-surface receptor or form
part of a large membrane-associated
complex that is capable of signaling
by several different pathways to
control cell proliferation and
differentiation. To further aid the
understanding of this enigmatic
protein, we have surveyed all the
intracellular regions for potential
domains that may suggest novel
functions and identify further
avenues for experiment.
The current model of polycystin-1
topology suggests that there are four
intracellular regions that are large
enough to contain a discrete protein
domain. These regions are between
transmembrane (TM) helices TM1
and TM2 (residues 3,096–3,280), TM3
and TM4 (residues 3,344–3,558), TM5
and TM6 (residues 3,603–3,668) and
the carboxy-terminal region after
TM11 (residues 4,105–4,302). The
high sequence conservation seen in
these regions between the human
and Fugu polycystin-1 suggest that
they are functionally important. We
have used each of these regions as a
query for the sequence comparison
program PSI-BLAST, using an
expectation-value (E-value) threshold
of 0.001 [7]. For each of the four
intracellular regions, PSI-BLAST
returned the known PKD1
orthologues from human, mouse and
Fugu. Only one region returned
significant matches with PSI-BLAST.
The first intracellular region between
TM1 and TM2, which represents the
most strongly conserved sequence
region of PKD1 between human and
Fugu [2], was found to match to 67
other sequences in SWISS-PROT
version 37 and TrEMBL version 9
[8]. These sequences include
mammalian lipoxygenases,
triacylglycerol lipase and lipoprotein
lipase. The common feature found in
Magazine R589
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A multiple sequence alignment of PLAT domains. The colouring scheme is that used in ClustalX. The secondary structures for the known structures
are shown below the sequences; E denotes β-strand.
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all these alignments was topological
and sequence similarity to a
β-sandwich domain. We call this new
protein domain the PLAT domain
(after polycystin-1, lipoxygenase and
alpha toxin). The copy of the PLAT
domain found in polycystin-1
therefore identifies an important new
region of the protein.
The three-dimensional structure
of the PLAT domain is known for
human pancreatic lipase [9], rabbit
15-lipoxygenase [10] and alpha toxin
from Clostridium perfringens [11]. The
domain is a β-sandwich composed of
two sheets of four strands each. The
sequence relationship of the alpha
toxin to polycystin-1 can be
demonstrated by using the sequence
of the PLAT domain from the
known structure as a query for PSI-
BLAST. The search essentially
converges to the same family,
including the polycystin-1 PLAT
domain. Soybean lipoxygenase L-1
[12] contains a domain structurally
related to the PLAT domains. It is
more distant in sequence to the rest
of the family; PSI-BLAST is able to
find relationships to the rest of the
family for only a few sequences.
Although structural similarities were
noticed between these structures, it
was not suggested that they share a
common ancestor [11].
The most highly conserved
regions in the alignment of known
PLAT domains (Figure 2) coincide
with the β-strands. Most of the
highly conserved residues are buried
residues. An exception to this is a
surface lysine or arginine that occurs
on the surface of the fifth β-strand of
all the eukaryotic PLAT domains. In
pancreatic lipase, the lysine in this
position forms a salt bridge with the
procolipase protein. The
conservation of a charged surface
residue may indicate the location of a
conserved ligand-binding site within
the PLAT domain.
The importance of PLAT
domains is underlined by mutations
that lead to human disease.
Mutations in lipoprotein lipase lead
to chylomicronaemia and mutations
in triacylglycerol lipase lead to
hepatic lipase deficiency [13]. In
pancreatic lipase the PLAT domain is
involved in binding to the procolipase
protein. This interaction is required
to bring the enzymatic active site of
the lipase into close contact with its
lipid substrate. In 15-lipoxygenase, a
protein composed of an amino-
terminal β-sandwich (PLAT) and a
carboxy-terminal catalytic domain,
the PLAT domain may function to
localise the enzyme near its
membrane or lipoprotein sequestered
substrates, by analogy to the
lipase–procolipase protein–protein
interaction. It is also possible that the
PLAT domain of 5-lipoxygenase,
another member of the mammalian
lipoxygenase family, mediates an
interaction with the 5-lipoxygenase
activating protein (FLAP), an integral
membrane protein. For alpha toxin
and plant lipoxygenases, it has been
suggested that the PLAT domain
interacts directly with the membrane
in a Ca2+ dependent manner.
Although a Ca2+-binding region has
been predicted for alpha toxin from
crystallographic data and similarity to
eukaryotic calcium-binding C2
domains [11], the conserved residues
that form this region are not present
in the PLAT domains identified in
polycystin-1 or pancreatic lipase.
PLAT domains may therefore be
involved in protein–protein and
protein–lipid interactions. The
presence of the PLAT domain in the
first cytoplasmic loop of polycystin-1
suggests that this region is important
in mediating interactions with other
membrane protein(s) involved in
polycystin-1 function. 
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The WSC domain
A PSI-BLAST [S1,S2] search of the region of PKD1 lying
between the leucine-rich repeat flanking regions and the
first PKD domain of PKD1 (amino acid residues 181–272)
using an expect value (E-value) inclusion threshold of
E < 0.01 revealed significant similarity to two regions of
Trichoderma harzianum β-1,3-exoglucanase [S3]
(E = 1 × 10–5 and 6 × 10–3) by iteration 1, and nine addi-
tional proteins (Figure S1) by convergence after five itera-
tions. Independent evidence for these domain
homologues and those discussed below was provided by
generalised profile analysis [S4], in which the significance
was better than p < 0.01 in all cases.
We term these homologues WSC domains, after S. cere-
visiae WSC1 (cell-wall integrity and stress-response com-
ponent 1; also called Slg1 and Hcs77), WSC2, WSC3 and
WSC4 proteins, which each contain a single such domain
[S5]. S. cerevisiae WSC1–3 proteins are localised to the
plasma membrane and function upstream of the
PKC1–MPK1 pathway [S5–S7]. The WSC domains in
these proteins are predicted to be extracellular and are
amino-terminal to serine- and threonine-rich regions, a
single predicted transmembrane sequence and divergent
carboxy-terminal cytoplasmic sequences. The functions of
these WSC domains are unknown but the WSC1–3 pro-
teins are suggested to act as sensors of environmental
stress [S5–S7], and WSC4 (also called Yhc8p) is implicated
in protein translocation to the endoplasmic reticulum [S8].
Tandem WSC domains are also found in a hypothetical
human protein (KIAA0523) that appears to be a member of
a novel sulphotransferase subfamily, and in the
T. harzianum β-1,3-exoglucanase [S3]. The latter occur-
rences indicate that the PKD1 WSC domain, and its homo-
logues in general, might possess a carbohydrate-binding
role. This would complement the predicted protein-,
lipoprotein- and carbohydrate-binding functions conferred
by the PKD, LDLα and C-type lectin domains of PKD1.
The LH2 domain
The cytoplasmic region between the first and second
transmembrane regions of PKD1 was found to contain a
β-barrel domain, homologous to a non-catalytic domain of
Supplementary material
Figure S1
Multiple sequence alignments of WSC
domains. Amino acid residues are coloured
according to a 80% consensus (calculated
using the program Consensus [S13]: +
indicates positively charged residues (H, K and
R, green); – indicates negatively charged
residues (D and E, green); a indicates aromatic
residues (F, H, W and Y, highlighted in yellow);
b indicates big residues (E, F, I, K, L, M, Q, R,
W and Y, grey or yellow); c indicates charged
residues (D, E, H, K and R, green); h indicates
hydrophobic residues (A, C, F, H, I, L, M, V, W
and Y, highlighted in yellow); l indicates
aliphatic residues (I, L and V, highlighted in
yellow); o indicates alcohol residues (S and T,
pink), p indicates polar residues (D, E, H, K, N,
Q, R, S and T, dark blue); s indicates small
residues (A, C, S, T, D, N, V, G and P, light
blue); u indicates tiny residues (A, G and S,
light blue). Residues that are predicted to form
disulphide bridges are shown as white-on-
black. Predicted [S14] secondary structures
are indicated below the alignment (e/E,
extended or β-strand structure; h/H, helix);
lowercase letters represent predictions that
have expected accuracies of > 72% and
uppercase letters represent predictions that
have expected accuracies of > 82%. Residue
numbers and GenBank identifiers are shown
following the alignment. Abbreviations: Fr,
Fugu rubripes; Hp, Hansenula polymorpha;
Hs, Homo sapiens; Sc, Saccharomyces
cerevisiae; Sp, Schizosaccharomyces pombe;
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lipoxygenases [S9]. A PSI-BLAST search [S1,S2] using
PKD1 residues 3,096–3,280 as query revealed significant
similarity (E < 10–6) by iteration 1 to the amino-terminal
domain of mammalian arachidonate 5-lipoxygenases
(Figure S2).  This domain has an eight-stranded β-barrel
fold [S9] and is highly similar in structure to the carboxy-
terminal domains of mammalian lipases [S10,S11] and the
amino-terminal domains of plant 15-lipoxygenases [S12]
(Figure S2). We term these domains lipoxygenase homol-
ogy 2 (LH2) domains. The current model for the function
of LH2 domains is that they facilitate binding of lipase
and lipoxygenase substrates to the enzymes’ active sites
[S9]. Thus the presence of this domain in the first cyto-
plasmic loop of PKD1 suggests a role in lipid-mediated
modulation of PKD1 function.
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Figure S2
Multiple alignment of LH2 domains, coloured
according to the consensus scheme of Figure
S1. Predicted [S14] secondary structures are
indicated below the alignment (e/E, extended
or β-strand structure; h/H, helix); lowercase
letters represent predictions that have
expected accuracies of > 72% and uppercase
letters represent predictions that have
expected accuracies of > 82%. Residue
numbers and GenBank identifiers are shown
following the alignment. Abbreviations: Ce,
Caenorhabditis elegans; Fr, Fugu rubripes;
Gm, Glycine max (soybean); Hs, Homo
sapiens; Mm, Mus musculus; Oc, Oryctolagus
cuniculus (rabbit); Rn, Rattus norvegicus;
LOX1, arachidonate 15-lipoxygenase; LIP2,
pancreatic lipase-related protein 2.
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